What’s the most efficient production platform for growth factors, pricey proteins used to stimulate cell growth and differentiation in cultivated meat?
Cultivated meat startup Omeat has emerged from stealth armed with $40m to fund a novel approach to making meat from animal cells.
UPSIDE Foods and GOOD Meat will be the first to launch cultivated meat in the US after clearing the final hurdles required by regulators.
UK-based Higher Steaks has rebranded as Uncommon and raised $30m in a series A round to scale production of cultivated pork using technology it claims gives it a competitive edge by speeding up the cell differentiation process.
Five or six years ago the press coverage around cultivated meat was almost universally positive. Today, we’re seeing headlines about cancerous cells, ‘vaporware,’ and business failures. So where does the industry go from here?
Some commentators argue that cultivated meat is a food tech fantasy. So are they right? It all depends on your approach, says Joshua March, cofounder and CEO at San Leandro-based startup SciFi Foods.
Dutch startup Meatable has slashed production times for cultivated pork from three weeks to eight days in the past year by dramatically speeding up the process by which its stem cells differentiate into fat and muscle, transforming its unit economics.
Dutch cultivated meat startup Mosa Meat has opened a new 30,000sq ft ‘scale-up plant’ in Maastricht as it edges closer to commercialization.
Israeli startup Ever After Foods (formerly Plurinuva) has unveiled technology it claims can transform the unit economics of cultivated meat by reducing the capex required to build facilities and increasing the productivity of tissue production.
Israeli startup Aleph Farms has struck deals enabling it to take an “asset-light” approach to scaling up cultivated meat production in Israel and Singapore. CEO Didier Toubia tells AFN Aleph is also scouting for sites in the US for a larger scale facility and believes it can achieve cost parity with premium beef by 2028.
The longtime entrepreneur describes the realities of founding a cultivated meat company, and offers insights for other founders and CEOs in the space.
Cell lines for cultivated meat R&D are proving hard to come by. But don’t point the finger of blame at startups, as a major UK newspaper appeared to do this week.
Ramping up production capacity is the top priority for GOOD Meat as Eat Just CEO says regulatory approval is less of a hurdle.
As part of the announcement, John Mackey, the CEO of Whole Foods, announced he was an investor in the company.
The Netherlands startup is now eight years old. We catch up with CEO Maarten Bosch to find out about its next steps.
The Netherlands-based startup is culturing meat in the lab using a technique that can change pluripotent stem cells from a newborn animal into any desired cell type.
Eat Just made history when it became the first company in the world to get regulatory approval to serve a cell-cultured meat product last November.
Aleph Farms claims the new technology will allow it to create any type of ‘muscle-cut’ steak and hopes to rapidly expand its product portfolio in the area.
Vinh Hoan’s new Vinh Technology division will “access strategic opportunities in agritech, foodtech, and biotech” as well as alt-protein, it said.
The US startup will use the convertible note financing to complete its pilot production facility in San Diego. But its next factory could very well be in Asia, says CEO Lou Cooperhouse.
Smoke & mirrors, not worth the extra cost: 50 US farmers speak out on carbon markets